750
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Prevalence and Patterns of Comorbidity Among Middle-Aged and Elderly People in China: A Cross-Sectional Study Based on CHARLS Data

, , ORCID Icon, , &
Pages 1449-1455 | Published online: 21 Apr 2021

References

  • Tang J, Liu WW. China’s aging process and some misunderstandings on it. J Beijing Univ Technol. 2018;18:8–18.
  • National Bureau of Statistics. National data 2019. Available from: http://data.stats.gov.cn/easyquery.htm?cn=C01. Accessed January 14, 2020.
  • World Health Organization. The World Health Report 2008. Primary Health Care (Now More Than Ever). Geneva: World Health Organization; 2008.
  • Sum G, Hone T, Atun R, et al. Multimorbidity and out-of-pocket expenditure on medicines: a systematic review. BMJ Global Health. 2018;3(1):e000505. doi:10.1136/bmjgh-2017-000505
  • Sum G, Salisbury C, Koh GC, et al. Implications of multimorbidity patterns on health care utilisation and quality of life in middle-income countries: cross-sectional analysis. J Glob Health. 2019;9(2):020413. doi:10.7189/jogh.09.020413
  • Yamada Y, Merz L, Kisvetrova H. Quality of life and comorbidity among older home care clients: role of positive attitudes toward aging. Qual Life Res. 2015;24(7):1661–1667. doi:10.1007/s11136-014-0899-x
  • Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43. doi:10.1016/S0140-6736(12)60240-2
  • Disease and Injury Incidence and Prevalence Collaborators (Collaborators DaIIaP). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858.
  • Tang C, Li MY, Wang B, et al. Prevalence of chronic disease among older people in Wuhan city and the knowledge, attitude, practice about chronic disease. Chin J Gerontol. 2017;37(5):1231–1234.
  • Schäfer I, von Leitner E, Schön G, et al. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One. 2010;5(12):e15941. doi:10.1371/journal.pone.0015941
  • Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61–68. doi:10.1093/ije/dys203
  • Hu X, Huang J, Lv Y, Li G, Peng X. Status of prevalence study on multimorbidity of chronic disease in China: systematic review. Geriatr Gerontol Int. 2015;15(1):1–10. doi:10.1111/ggi.12340
  • Kim J, Keshavjee S, Atun R. Trends, patterns and health consequences of multimorbidity among South Korea adults: analysis of nationally representative survey data 2007–2016. J Glob Health. 2020;10(2):020426. doi:10.7189/jogh.10.020426
  • Kirchberger I, Meisinger C, Heier M, et al. Patterns of multimorbidity in the aged population. Results from the KORA-Age study. PLoS One. 2012;7(1):e30556. doi:10.1371/journal.pone.0030556
  • Wang R, Yan Z, Liang Y, et al. Prevalence and patterns of chronic disease pairs and multimorbidity among older Chinese adults living in a rural area. PLoS One. 2015;10(9):e0138521. doi:10.1371/journal.pone.0138521
  • Sinnige J, Braspenning J, Schellevis F, Stirbu-Wagner I, Westert G, Korevaar J. The prevalence of disease clusters in older adults with multiple chronic diseases–a systematic literature review. PLoS One. 2013;8(11):e79641. doi:10.1371/journal.pone.0079641
  • Mancusi C, Izzo R, Di Gioia G, Losi MA, Barbato E, Morisco C. Insulin resistance the hinge between hypertension and type 2 diabetes. High Blood Press Cardiovasc Prev. 2020;27(6):515–526. doi:10.1007/s40292-020-00408-8
  • Oliveros E, Patel H, Kyung S, et al. Hypertension in older adults: assessment, management, and challenges. Clin Cardiol. 2020;43(2):99–107. doi:10.1002/clc.23303
  • Gu DF, Weng JP, Lu XF. Chinese guideline on healthy lifestyle to prevent cardiometabolic diseases. Chin Circ J. 2020;35(3):209–230.
  • Li X, Krumholz HM, Yip W, et al. Quality of primary health care in China: challenges and recommendations. Lancet. 2020;395(10239):1802–1812. doi:10.1016/S0140-6736(20)30122-7
  • Liang X, Gu D, Zhang H, et al. The analysis of drug cost and direct medical expense in community of health management of hypertensive patients. Chin J Prev Med. 2011;45(8):732–736.
  • Wang XW, Yao SS, Wang MY, et al. Multimorbidity among two million adults in China. Int J Environ Res Public Health. 2020;17(10):3395. doi:10.3390/ijerph17103395
  • Pearson-Stuttard J, Ezzati M, Gregg EW. Multimorbidity-a defining challenge for health systems. Lancet Public Health. 2019;4(12):e599–e600. doi:10.1016/S2468-2667(19)30222-1
  • Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition-multimorbidity. JAMA. 2012;307(23):2493–2494. doi:10.1001/jama.2012.5265
  • Bao X, Xie Y, Zhang X, et al. The association between multimorbidity and health-related quality of life: a cross-sectional survey among community middle-aged and elderly residents in southern China. Health Qual Life Outcomes. 2019;17(1):107. doi:10.1186/s12955-019-1175-0
  • Zhao Y, Atun R, Oldenburg B, et al. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. Lancet Global Health. 2020;8(6):e840–e849. doi:10.1016/S2214-109X(20)30127-3
  • Wu XL, Xu H, Yu Q, et al. Evaluation of intervention effect of health management on chronic diseases in the elderly. Chin J Dis Control Prev. 2018;22(6):573–576.